2238 Dicker, Adam P. - Thomas Jefferson University - Thomas Jefferson University
axd121

Adam P. Dicker, MD, PhD

Contact Dr. Dicker

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6700
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. AAPM and GEC-ESTRO guidelines for image-guided robotic brachytherapy: Report of Task Group 192
  2. The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?
  3. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  4. The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905
  5. High dose rate brachytherapy boost for prostate cancer: A systematic review
  6. Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
  7. A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect
  8. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  9. Vorinostat as a radiosensitizer for brain metastasis: A phase i clinical trial
  10. The quality frontier
  11. High-priority topics for cancer quality measure development: Results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit
  12. Study of unrecovered strain and critical stresses in one-way shape memory Nitinol
  13. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma
  14. Hsp90 inhibition enhances PI-3 kinase inhibition and radiosensitivity in glioblastoma
  15. MicroRNAs: The short link between cancer and RT-induced DNA damage response
  16. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
  17. A model to predict deflection of bevel-tipped active needle advancing in soft tissue
  18. Polyacrylamide phantom for self-actuating needle-tissue interaction studies
  19. The antiangiogenic effects of a vascular endothelial growth factor decoy receptor can be monitored in vivo using contrast-enhanced ultrasound imaging
  20. Radiation therapy and the immune system: Learning to live together
0